Literature DB >> 24647548

Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells.

Taro Yamashita1, Shuichi Kaneko.   

Abstract

Hepatocellular carcinoma (HCC) is one of the world's most aggressive diseases and carries a poor prognosis for patients. Recent evidence suggests that HCC is organized by cancer stem cells (CSCs), which are a subset of cells with stem cell-like features. CSCs are considered a pivotal target for the eradication of cancer, and liver CSCs have been investigated using various stem cell markers. Several hepatic stem/progenitor markers have been shown to be useful for isolating putative CSCs from HCC, although the expression patterns and phenotypic diversity of CSCs purified by these markers remain obscure. Recently, we found that liver CSCs defined by different markers show unique features of tumorigenicity and metastasis, with phenotypes closely associated with committed liver lineages. Furthermore, our data suggest that these distinct CSCs collaborate to orchestrate the tumorigenicity and metastasis of HCC. In this review article, we summarize the recent advances in understanding the pathogenesis and heterogeneity of liver CSCs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24647548     DOI: 10.1007/s00535-014-0951-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  68 in total

1.  DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma.

Authors:  Xiao Xu; Rui-Fang Liu; Xin Zhang; Li-Yu Huang; Fei Chen; Qian-Lan Fei; Ze-Guang Han
Journal:  Mol Cancer Ther       Date:  2012-01-11       Impact factor: 6.261

2.  Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.

Authors:  Christine Gauglhofer; Sandra Sagmeister; Waltraud Schrottmaier; Carina Fischer; Chantal Rodgarkia-Dara; Thomas Mohr; Stefan Stättner; Christoph Bichler; Daniela Kandioler; Fritz Wrba; Rolf Schulte-Hermann; Klaus Holzmann; Michael Grusch; Brigitte Marian; Walter Berger; Bettina Grasl-Kraupp
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

3.  Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.

Authors:  Hsiang-Po Huang; Pin-Hsun Chen; Chun-Ying Yu; Ching-Yu Chuang; Lee Stone; Wen-Chu Hsiao; Chung-Leung Li; Shih-Chih Tsai; Kai-Yun Chen; Hsin-Fu Chen; Hong-Nerng Ho; Hung-Chih Kuo
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

4.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

5.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

6.  EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Authors:  Taro Yamashita; Marshonna Forgues; Wei Wang; Jin Woo Kim; Qinghai Ye; Huliang Jia; Anuradha Budhu; Krista A Zanetti; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

7.  Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

Authors:  Stephanie Ma; Kwok Wah Chan; Terence Kin-Wah Lee; Kwan Ho Tang; Jana Yim-Hung Wo; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

Review 8.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

9.  Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma.

Authors:  Federico Colombo; Francesca Baldan; Silvia Mazzucchelli; Ines Martin-Padura; Paola Marighetti; Alessandra Cattaneo; Barbara Foglieni; Marta Spreafico; Silvana Guerneri; Marco Baccarin; Francesco Bertolini; Giorgio Rossi; Vincenzo Mazzaferro; Massimiliano Cadamuro; Marco Maggioni; Luca Agnelli; Paolo Rebulla; Daniele Prati; Laura Porretti
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

10.  Human hepatic stem cells from fetal and postnatal donors.

Authors:  Eva Schmelzer; Lili Zhang; Andrew Bruce; Eliane Wauthier; John Ludlow; Hsin-lei Yao; Nicholas Moss; Alaa Melhem; Randall McClelland; William Turner; Michael Kulik; Sonya Sherwood; Tommi Tallheden; Nancy Cheng; Mark E Furth; Lola M Reid
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  23 in total

1.  Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice.

Authors:  Liansheng Zhong; Ji Na Kong; Michael B Dinkins; Silvia Leanhart; Zhihui Zhu; Stefka D Spassieva; Haiyan Qin; Hsuan-Pei Lin; Ahmed Elsherbini; Rebecca Wang; Xue Jiang; Mariana Nikolova-Karakashian; Guanghu Wang; Erhard Bieberich
Journal:  J Lipid Res       Date:  2018-03-22       Impact factor: 5.922

2.  Prolonged hypoxia switched on cancer stem cell-like plasticity in HepG2 tumourspheres cultured in serum-free media.

Authors:  Ain Zubaidah Ayob; Thamil Selvee Ramasamy
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-11-08       Impact factor: 2.416

Review 3.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

4.  Quinoides and VEGFR2 TKIs influence the fate of hepatocellular carcinoma and its cancer stem cells.

Authors:  Deniz Cansen Kahraman; Gilles Hanquet; Loïc Jeanmart; Steve Lanners; Peter Šramel; Andrej Boháč; Rengul Cetin-Atalay
Journal:  Medchemcomm       Date:  2016-10-07       Impact factor: 3.597

5.  Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features.

Authors:  Hyungjin Rhee; Chansik An; Hye-Young Kim; Jeong Eun Yoo; Young Nyun Park; Myeong-Jin Kim
Journal:  Liver Cancer       Date:  2018-05-15       Impact factor: 11.740

6.  Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.

Authors:  Zhen-Guo Zhao; De-Qiang Wang; De-Fei Hu; You-Sheng Li; Shuang-Hai Liu
Journal:  Onco Targets Ther       Date:  2016-03-23       Impact factor: 4.147

7.  Fusion with stem cell makes the hepatocellular carcinoma cells similar to liver tumor-initiating cells.

Authors:  Ran Wang; Shuxun Chen; Changxian Li; Kevin Tak Pan Ng; Chi-wing Kong; Jinping Cheng; Shuk Han Cheng; Ronald A Li; Chung Mau Lo; Kwan Man; Dong Sun
Journal:  BMC Cancer       Date:  2016-02-04       Impact factor: 4.430

8.  Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes.

Authors:  Rui Yang; Li Y An; Qin F Miao; Feng M Li; Yong Han; Hui X Wang; Dang P Liu; Rong Chen; Sha Q Tang
Journal:  Oncotarget       Date:  2016-06-14

Review 9.  Cancer stem cells in human gastrointestinal cancer.

Authors:  Hiroaki Taniguchi; Chiharu Moriya; Hisayoshi Igarashi; Anri Saitoh; Hiroyuki Yamamoto; Yasushi Adachi; Kohzoh Imai
Journal:  Cancer Sci       Date:  2016-11       Impact factor: 6.716

10.  Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study.

Authors:  Ji Hae Nahm; Hyungjin Rhee; Haeryoung Kim; Jeong Eun Yoo; Jee San Lee; Youngsic Jeon; Gi Hong Choi; Young Nyun Park
Journal:  Oncotarget       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.